文献速递中药与中成药合理使用中医内科

白首乌三种基原植物的传统应用、化学成分与药理活性综述

Cynanchum bungei Decne and its two related species for "Baishouwu": A review on traditional uses, phytochemistry, and pharmacological activities.
PubMed 文献 · J Ethnopharmacol · 2019-07-24

本文综述白首乌(Cynanchum bungei Decne.及其近缘种C. auriculatum、C. wilfordii)的传统用途、化学成分与药理活性。文献检索显示已分离151种化合物,主要为苯乙酮类、C21甾体、萜类和生物碱,具抗肿瘤、抗炎、免疫调节、降脂、保肝等活性。传统补肝作用与保肝活性相关,活性多归因于苯乙酮类和C21甾体,需进一步研究机制、构效关系及毒理。

要点

  • 白首乌三种基原传统用于补肝肾、强筋骨,CB还用于胃痛。
  • 已分离151种化合物,主要成分为苯乙酮类、C21甾体、萜类和生物碱。
  • 药理活性包括抗肿瘤、抗炎、免疫调节、降脂、保肝等,补肝与保肝相关。

核心结论

  • CB、CA和CW统称白首乌,是有多种药理活性的有价值药材。
  • 传统补肝用途与保肝活性密切相关。
  • 白首乌多种活性可归因于苯乙酮类和C21甾体。

研究设计与样本

  • 综述通过SciFinder、Pubmed、Elsevier、Google Scholar、Web of Science和Baidu Scholar等数据库检索CB、CA和CW文献。
  • 信息还来自当地经典本草文献和民族药理学会议论文,并取自同行评议论文。

主要发现

  • CB的民族药理学用途记录于中国,CA和CW在中国、韩国和日本有使用。
  • 已从这些物种中分离出151种化合物。
  • 主要化学成分为苯乙酮类、C21甾体、萜类和生物碱。
  • 这些化合物和提取物已被证明具有抗肿瘤、抗炎、免疫调节、降脂、抗肥胖、保肝、抗真菌、抗病毒、抗抑郁、血管舒张和雌激素样活性。

临床怎么用

  • 传统补肝肾、强筋骨用途有保肝活性支持,但具体用法用量原文未报告。
  • 苯乙酮类和C21甾体可能是主要活性成分,但需进一步研究机制和构效关系。
  • 需关注毒理学评价以确保安全性和有效性。

局限性

  • 需进一步研究有益生物活性的机制和成分的构效关系。
  • 需研究成分的潜在协同和拮抗效应。
  • 适当的毒理学评价对保证安全性、有效性和药用资格至关重要。
  • 需进一步研究白首乌的药材质量综合评价和多靶点网络药理学。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

ETHNOPHARMACOLOGICAL RELEVANCE: Cynanchum bungei Decne. (CB) (Asclepiadaceae) and its two related species Cynanchum auriculatum Royle ex Wight. (CA) and Cynanchum wilfordii (Maxim.) Hemsl. (CW) are well known Chinese herbal medicines known by the name Baishouwu. Among them, CB has long been used for nourishing the kidney and liver, strengthening the bones and muscles, and regulating stomachache. However, to date, no comprehensive review on Baishouwu has been published. AIM OF THE REVIEW: This review aims to provide a comprehensive summary on traditional uses, phytochemistry, pharmacology, and toxicology of the three herbal components of Baishouwu with the ultimate objective of providing a guide for future scientific and therapeutic potential use of Baishouwu. MATERIAL AND METHODS: A literature search was undertaken on CB, CA and CW by analyzing the information from scientific databases (SciFinder, Pubmed, Elsevier, Google Scholar, Web of Science, and Baidu Scholar). Information was also gathered from local classic herbal literatures and conference papers on ethnopharmacology and the information provided in this review has been obtained from peer-reviewed papers. RESULTS: Comparative analysis of literature search indicate that ethnopharmacological use of CB was recorded in China, however, CA and CW have been used in China, Korea and Japan. To date, 151 chemical compounds have been isolated from these species, and the major chemical constituents have been revealed to be acetophenones, C21-steroids, terpenoids, and alkaloids. These compounds and extracts have been proven to exhibit significant pharmacological activities, including anti-tumor, anti-inflammatory, immunomodulatory, hypolipidemic, anti-obesity, hepatoprotective, antifungal, antiviral, anti-depressant, vasodilating and estrogenic activities. CONCLUSIONS: CB, CA and CW collectively known as Baishouwu are valuable medicinal herbs with multiple pharmacological activities. The traditional use for nourishing liver is closely associated with the hepatoprotective activity. The available literature performs that various of the activity of Baishouwu can be attributed to acetophenones and C21-steroids. It is high time that more efforts should be focused on the underlying mechanisms of their beneficial bioactivities and the structure activity relationship of the constituents, as well as their potential synergistic and antagonistic effects. The proper toxicology evaluation is crucial to guarantee the safety, efficacy, and eligibility for medical use. Further research on the comprehensive evaluation of medicinal quality and the understanding of multi-target network pharmacology of Baishouwu is in great request.

来源:J Ethnopharmacol,查看原文。版权归原作者所有。

引用

  1. Chen WH, Zhang ZZ, Ban YF, et al. Cynanchum bungei Decne and its two related species for "Baishouwu": A review on traditional uses, phytochemistry, and pharmacological activities. J Ethnopharmacol. 2019. PMID: 31351190. doi:10.1016/j.jep.2019.112110

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。